ArticleHematology reports2023

Feasibility of Quality of Life Assessment in Patients with Lymphoma Aged ≥80 Years Receiving Reduced-Intensity Chemotherapy: A Single-Institute Study.

Satoshi YamasakiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.